These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38001442)

  • 1. Promoting data harmonization to evaluate vaccine hesitancy in LMICs: approach and applications.
    Rego RT; Zhukov Y; Reneau KA; Pienta A; Rice KL; Brady P; Siwo GH; Wachira PW; Abubakar A; Kollman K; Waljee AK
    BMC Med Res Methodol; 2023 Nov; 23(1):278. PubMed ID: 38001442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Informing efforts beyond tailored promotional campaigns by understanding contextual factors shaping vaccine hesitancy among equity-deserving populations in Canada: an exploratory qualitative study.
    Nascimento LG; Dubé È; Burns KE; Brown P; Calnan M; Ward PR; Filice E; Herati H; Ike NAU; Rotolo B; Meyer SB
    Int J Equity Health; 2023 Oct; 22(1):209. PubMed ID: 37805472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine hesitancy among healthcare workers in low- and middle-income countries during the COVID-19 pandemic: Results from facility surveys across six countries.
    Baral P; Ahmed T; Amor Fernandez P; Peters MA; Drouard SHP; Muhoza P; Mwinnyaa G; Mwansambo C; Nzelu C; Tassembedo M; Uddin MH; Wesseh CS; Yansane ML; Bergeron JR; Karibwami AD; Lopez Chicheri TIOZ; Ogunlayi MIA; Sieleunou I; Hashemi T; Hansen PM; Shapira G
    PLoS One; 2023; 18(7):e0288124. PubMed ID: 37418435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding determinants of vaccine hesitancy and acceptance in India: A qualitative study of government officials and civil society stakeholders.
    Erchick DJ; Gupta M; Blunt M; Bansal A; Sauer M; Gerste A; Holroyd TA; Wahl B; Santosham M; Limaye RJ
    PLoS One; 2022; 17(6):e0269606. PubMed ID: 35679276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How prevalent is COVID-19 vaccine hesitancy in low-income and middle-income countries and what are the key drivers of hesitancy? Results from 53 countries.
    Dayton Eberwein J; Edochie IN; Newhouse D; Cojocaru A; Bopahbe GD; Kakietek JJ; Kim YS; Montes J
    BMJ Open; 2023 Nov; 13(11):e069152. PubMed ID: 37931970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What message appeal and messenger are most persuasive for COVID-19 vaccine uptake: Results from a 5-country survey in India, Indonesia, Kenya, Nigeria, and Ukraine.
    Limaye RJ; Balgobin K; Michel A; Schulz G; Erchick DJ
    PLoS One; 2022; 17(9):e0274966. PubMed ID: 36129894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of COVID-19 vaccine hesitancy in Sub-Saharan Africa: evidence from panel survey data.
    Wollburg P; Markhof Y; Kanyanda S; Zezza A
    BMC Proc; 2023 Jul; 17(Suppl 7):8. PubMed ID: 37415169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging 13 million responses to the U.S. COVID-19 Trends and Impact Survey to examine vaccine hesitancy, vaccination, and mask wearing, January 2021-February 2022.
    Nguyen QC; Yardi I; Gutierrez FXM; Mane H; Yue X
    BMC Public Health; 2022 Oct; 22(1):1911. PubMed ID: 36229804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An empirical assessment of the factors influencing acceptance of COVID-19 vaccine uptake between Kenyan and Hungarian residing populations: A cross-sectional study.
    Macharia JM; Gakenye GW; Rozmann N; Onchonga D; Mwangi RW; Kaposztas Z; Mathenge JM; Pusztai D; Pinter M; Sugar M; Raposa BL
    Sci Rep; 2022 Dec; 12(1):22262. PubMed ID: 36564451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine hesitancy and equity: lessons learned from the past and how they affect the COVID-19 countermeasure in Indonesia.
    Sinuraya RK; Nuwarda RF; Postma MJ; Suwantika AA
    Global Health; 2024 Feb; 20(1):11. PubMed ID: 38321478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccine hesitancy among non-refugees and refugees in Kenya.
    Rego RT; Ngugi AK; Sophie Delius AJ; Luchters S; Kolars JC; Irfan FB; Weinheimer-Haus E; Abubakar A; Shah R; Zhu J; Boulton ML; Hofer T; Waljee AK
    PLOS Glob Public Health; 2022; 2(8):e0000917. PubMed ID: 36962839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The determinants of SARS-CoV-2 vaccine hesitancy in a rural area of an Indonesia-Philippines border island: A mixed-method study].
    Simanjorang C; Pangandaheng N; Tinungki Y; Medea GP
    Enferm Clin; 2022; 32(6):376-384. PubMed ID: 35261543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccine hesitancy: assessing the prevalence, predictors, and effectiveness of a community pharmacy based counseling intervention.
    Kiptoo J; Isiiko J; Yadesa TM; Rhodah T; Alele PE; Mulogo EM
    BMC Public Health; 2024 Jan; 24(1):111. PubMed ID: 38184570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Vaccine Acceptance and Uptake in Bangkok, Thailand: Cross-sectional Online Survey.
    Remmel C; Tuli G; Varrelman TJ; Han AR; Angkab P; Kosiyaporn H; Netrpukdee C; Sorndamrih S; Thamarangsi T; Brownstein JS; Astley CM
    JMIR Public Health Surveill; 2023 Apr; 9():e40186. PubMed ID: 36811852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining enablers of vaccine hesitancy toward routine childhood and adolescent vaccination in Malawi.
    Adeyanju GC; Betsch C; Adamu AA; Gumbi KS; Head MG; Aplogan A; Tall H; Essoh TA
    Glob Health Res Policy; 2022 Aug; 7(1):28. PubMed ID: 35978401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination hesitancy: To be vaccinated, or not to be vaccinated, that is the question in the era of COVID-19.
    Perrone C; Fiabane E; Maffoni M; Pierobon A; Setti I; Sommovigo V; Gabanelli P
    Public Health Nurs; 2023 Jan; 40(1):90-96. PubMed ID: 36168152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake.
    Moradpour J; Shajarizadeh A; Carter J; Chit A; Grootendorst P
    PLoS One; 2023; 18(11):e0293184. PubMed ID: 37917650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine hesitancy in the Gulf Cooperation Council countries.
    Algabbani A; AlOmeir O; Algabbani F
    East Mediterr Health J; 2023 May; 29(5):402-411. PubMed ID: 37306176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs.
    Qunaibi EA; Helmy M; Basheti I; Sultan I
    Elife; 2021 May; 10():. PubMed ID: 34042047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptance of COVID-19 vaccine among sub-Saharan Africans (SSA): a comparative study of residents and diasporan dwellers.
    Miner CA; Timothy CG; Percy K; Mashige ; Osuagwu UL; Envuladu EA; Amiebenomo OM; Ovenseri-Ogbomo G; Charwe DD; Goson PC; Ekpenyong BN; Abu EK; Langsi R; Oloruntoba R; Ishaya T; Agho KE
    BMC Public Health; 2023 Jan; 23(1):191. PubMed ID: 36709269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.